App review

MyNetDiary GLP-1 — review

MyNetDiary's GLP-1 mode is the most-developed dedicated GLP-1 workflow among the apps reviewed. RD-favored on the dedicated-mode reason, with a dietitian-curated database and a functional free tier. Photo logging and UI design are the main weak points.

MyNetDiary’s GLP-1 mode, launched as a dedicated workflow in late 2024 and significantly expanded across 2025, is the most-developed dedicated GLP-1 workflow among the apps reviewed on this site. It is the strongest pick for patients (and the RDs and CDCES practitioners supporting them) for whom a built-in GLP-1 workflow is the deciding criterion.

What “dedicated GLP-1 workflow” actually means in MyNetDiary

The GLP-1 mode in MyNetDiary modifies the standard tracking workflow in several specific ways:

• Meals can be logged with GLP-1-relevant context flags: “small meal,” “partial meal,” “could not finish,” and a free-text side-effect note (nausea, early satiety, dose-day) that becomes available in the dietitian-review export.
• The home view surfaces protein and fiber against personalized targets, with calories displayed but de-emphasized — appropriate for the GLP-1 patient whose calorie intake is already lower than a typical tracker default would target.
• The food database has been curated for GLP-1 patient relevance: protein-dense smaller portions, lower-fat options for nausea management, and fiber-forward options for constipation.
• A “dose-day notes” section lets patients capture the date, dose, injection site, and side-effect timeline of each weekly injection — useful when reviewing patterns with a clinician across months.

This is, in practice, the design that GLP-1 patients ask their RD for: a tracker that does not pretend the patient is going to eat three structured meals.

Database curation matters more than database size

The largest food database in the consumer market is MyFitnessPal’s; the second-largest is probably Lose It’s. MyNetDiary’s is smaller but is dietitian-curated, which means relatively few duplicate or low-quality entries and a higher proportion of clinically-relevant foods (lower-fat protein options, prepared meals with full macronutrient breakdowns, common protein-shake products). For a GLP-1 patient already navigating a complex eating pattern, the smaller-but-cleaner database typically produces less search friction than a larger-but-noisier one.

Free tier is genuinely functional

The MyNetDiary GLP-1 free tier supports the GLP-1 mode, basic logging, target tracking, and the dose-day notes. The Premium tier (currently around $59.99/yr) adds advanced reports, longer history, and additional dietitian-review export options. This is a meaningfully different free-tier proposition than MyFitnessPal, where the free-tier limitations have grown more substantial over the past two years.

Where MyNetDiary GLP-1 falls short

• Photo logging is weak. Photo logging in MyNetDiary works but is slow and inaccurate compared with PlateLens or Cal AI. Patients prioritizing photo speed for smaller, more frequent meals will find the typed-and-barcode workflow more friction than they want.
• UI design is dated. Several workflows require more taps than competitor apps. For some patients this is acceptable; for others it is the friction that makes them stop using the app.
• Wearable integrations are limited compared with PlateLens or MacroFactor.
• Data portability out of MyNetDiary is harder than out of more recent apps; patients planning to switch trackers later should think about this in advance.

When to pick MyNetDiary GLP-1

The clearest case for MyNetDiary GLP-1 over PlateLens or Cronometer is when a built-in GLP-1 workflow — including the dose-day log and the side-effect note pattern — is the criterion that matters most. The clearest case against is when photo-logging speed for smaller, more frequent meals is the primary criterion; PlateLens fits that case better.

For RDs and CDCES practitioners working with GLP-1 patients, MyNetDiary’s web-companion review interface is well-developed and may be the deciding factor in clinical workflow.

References

1. American Diabetes Association. Standards of Care in Diabetes — 2025: Section 8, Obesity and weight management for the prevention and treatment of type 2 diabetes. Diabetes Care. 2025;48(Suppl 1):S145-S157.
2. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
3. Holmstrup ME, Fairman CM, Calanna S, et al. Body composition during pharmacologic weight loss with GLP-1 receptor agonists: implications for protein adequacy and resistance training. Obesity Reviews. 2025;26(4):e13721.
4. Tay J, Brinkworth GD, Thompson CH, et al. Comparative effectiveness of dietitian-supported app-based nutritional intervention versus standard care in adults with type 2 diabetes initiating GLP-1 therapy. Diabetes Care. 2025;48(7):1422-1431.

GLP-1 Nutrition does not accept payment, affiliate revenue, or sponsorship from any app developer. App reviews are funded by editorial budget only. Editorial policy: /about/editorial-policy/.